Clinical trial
Treatment With Radiolabeled Monoclonal Antibody HuJ591-GS (177Lu-J591) in…
NCT00195039 · Weill Medical College of Cornell University, Other · Completed
Key facts
| NCT number | NCT00195039 |
|---|---|
| Title | Treatment With Radiolabeled Monoclonal Antibody HuJ591-GS (177Lu-J591) in Patients With Metastatic Prostate Cancer |
| Official title | A Phase 2 Trial of 177Lu Radiolabeled Monoclonal Antibody HuJ591-GS (177Lu-J591) in Patients With Metastatic Androgen-Independent Prostate Cancer |
| Lead sponsor | Weill Medical College of Cornell University, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Prostate Cancer |
| Intervention type | Drug |
| Interventions | 177Lu Radiolabeled Monoclonal Antibody HuJ591 (177Lu -J591) |
| Enrollment | 47 |
| Start date | Aug 1, 2004 |
| Primary completion | Feb 1, 2012 |
| Completion | Oct 1, 2013 |
| First posted | Sep 19, 2005 |
| Last update posted | Oct 5, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: